Try it
Biochemistry · Protein degradation: ubiquitin-proteasome system
Sample itemA patient with multiple myeloma is treated with bortezomib. Which mechanism underlies its action?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Inhibition of the 26S proteasome, so ubiquitin-tagged proteins accumulate and plasma cells undergo apoptosis
Proteins destined for destruction are tagged with chains of ubiquitin (usually linked through lysine 48) and degraded by the 26S proteasome in an ATP-dependent step. Plasma cells make huge amounts of immunoglobulin and depend on proteasomal clearance of misfolded protein, and proteasome inhibition also stabilises IkB and blocks NF-kB. Peripheral neuropathy is a characteristic adverse effect.
Option by option
A. Inhibition of the mTOR kinase
mTOR inhibition is the action of sirolimus and everolimus.
B. Inhibition of topoisomerase II
Topoisomerase II inhibition is the action of etoposide and anthracyclines.
C. Inhibition of the 26S proteasome, so ubiquitin-tagged proteins accumulate and plasma cells undergo apoptosis (correct)
Proteasome inhibition causes build-up of misfolded proteins and suppresses NF-kB survival signalling in myeloma cells.
D. Inhibition of histone deacetylase
HDAC inhibition is the action of vorinostat.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…